Donafenib Plus Sintilimab for Advanced HCC
Clinical trial NCT05162352 · COMPLETED
Trial details
- NCT number
- NCT05162352
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-04
- Primary completion
- 2022-10-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.